Clinical Trials Browser

Unknown × tislelizumab × CNS × Clear all

NCT05811793 2023-04-13

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Phase NA Unknown

Glioblastoma

NCT05207904 2022-01-26

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Phase 2 Unknown

Brain Neoplasms